5 Key Takeaways
-
1
The video interview features Delara Motlagh, chief operating officer at Fujifilm Cellular Dynamics.
-
2
Motlagh discusses her career and the evolution of cell and gene therapy over more than 2 decades.
-
3
She reflects on experiences that have shaped her leadership approach.
-
4
Motlagh discusses solving complex manufacturing problems and the promise of induced pluripotent stem cells in research and therapeutics.
-
5
She considers how contract development and manufacturing organizations and technology providers can help make advanced therapies more accessible.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
